A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.
NCT ID: NCT00196352
Last Updated: 2014-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
320 participants
INTERVENTIONAL
2003-05-31
2006-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
NCT00196365
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
NCT00196313
Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive
NCT00196326
Study of Safety and Efficacy of an Oral Contraceptive
NCT00477633
Study of Safety and Efficacy of an Oral Contraceptive
NCT00391807
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Levonorgestrel/EE 0.15/0.03 mg and EE 0.01 mg tablets
1 tablet daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Levonorgestrel/EE 0.15/0.03 mg and EE 0.01 mg tablets
1 tablet daily
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duramed Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Duramed Research, Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Duramed Protocol Chair
Role: STUDY_CHAIR
Duramed Research, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duramed Investigational Site
Tucson, Arizona, United States
Duramed Investigational Site
Washington D.C., District of Columbia, United States
Duramed Investigational Site
Lincoln, Nebraska, United States
Duramed Investigational Site
Rochester, New York, United States
Duramed Investigational Site
Charlotte, North Carolina, United States
Duramed Investigational Site
Winston-Salem, North Carolina, United States
Duramed Investigational Site
Columbus, Ohio, United States
Duramed Investigational Site
Oklahoma City, Oklahoma, United States
Duramed Investigational Site
Nashville, Tennessee, United States
Duramed Investigational Site
Arlington, Virginia, United States
Duramed Investigational Site
Norfolk, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PSE-304
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.